通过皮肤冠状动脉干预后心房的患者进行抗血栓治疗
Mark Anthony Sammut1,2, Robert F Storey1,2
1Cardiovascular Research Unit, Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.
Expert review of cardiovascular therapy
|October 21, 2024
概括
均衡出血风险和缺血性保护对于接受三重抗血栓治疗 (TAT) 的患者至关重要. 新的P2Y12抑制剂可能提供更安全,更有效的抗血栓策略,通过皮肤冠状动脉干预后 (PCI).
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 通过皮肤冠状动脉干预 (PCI) 进行支架的患者通常需要双重抗血小板治疗 (DAPT).
- 口服抗凝药 (OAC) 的同时存在的指示,如心房动 (AF),需要三重抗血栓治疗 (TAT),引发了对过度出血的担忧.
- 在TAT患者中,出血风险和缺血事件预防之间的最佳平衡是正在进行的研究的主题.
研究的目的:
- 审查具有里程碑意义的临床试验和比较TAT与双抗血栓治疗 (DAT) 的元分析.
- 概述当前针对PCI和OAC症状同时存在的患者抗血栓治疗方案的国际建议.
- 为了确定未解决的问题和未来的研究方向在管理抗血栓治疗.
主要方法:
- 关键临床试验的审查,将TAT与DAT进行比较.
- 对这些试验的后续元分析的分析.
- 对国际指导方针和有关抗血栓策略的专家意见的审查.
主要成果:
- 目前的建议往往有利于短时间的TAT,通常是用克洛皮多格雷尔,随后是阿司匹林戒断.
- 新出现的证据表明,蒂卡格勒或普拉苏格勒可能会提供更一致的P2Y12抑制.
- 在没有OAC指示的PCI后患者中,单独使用蒂卡格勒治疗显示出有前途.
结论:
- 在PCI后立即使用蒂卡格勒或普拉苏格勒的双重抗血栓治疗 (DAT) 可能在特定患者中代表基于克洛皮多格勒的疗法更安全,更有效的替代方案.
- 需要进行进一步的试验,以建立最佳的抗血栓策略,平衡有效性和安全性.
- 个性化抗血栓治疗方案对于患有复杂心血管疾病的患者至关重要.
相关概念视频
01:29Venous Thrombosis III: Interprofessional Care
2
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
2
01:28Acute Coronary Syndrome IV: Interprofessional Care
3
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
3
01:27Peripheral Artery Disease III: Interprofessional Care
2
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
2
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
1
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
1
01:27Coronary Artery Disease V: Surgical Management
3
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
3
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
478
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
478